Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)

ClinicalTrials.gov ID: NCT05027074

Public ClinicalTrials.gov record NCT05027074. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Parallel-group, Placebo-controlled, Double-blind, Event-driven, Multi-center Phase 2 Clinical Outcome Trial of Prevention of Arteriovenous Graft Thrombosis and Safety of MK-2060 in Patients With End Stage Renal Disease Receiving Hemodialysis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of two different doses of MK-2060 (a monoclonal antibody against Factor XI) in end stage renal disease (ESRD) participants receiving hemodialysis via an arteriovenous graft (AVG). Data from this study will be used to aid dose selection of MK-2060 in future studies. The primary hypothesis is that at least one of the MK-2060 doses is superior to placebo in increasing the time to first occurrence of AVG event.

Study identification

NCT ID
NCT05027074
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
506 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 17, 2021 (Actual)
Primary completion
Oct 30, 2024 (Actual)
Completion
Feb 13, 2025 (Actual)
Last update posted
Feb 11, 2026

2021 – 2025

United States locations

U.S. sites
77
U.S. states
25
U.S. cities
62
Facility City State ZIP Site status
Nephrology Consultants ( Site 0681) Huntsville Alabama 35805 —
AKDHC MEDICAL RESEARCH SERVICES, LLC-Maryvale ( Site 0723) Phoenix Arizona 85035 —
AKDHC Medical Research Services, LLC ( Site 0629) Tucson Arizona 85741 —
DaVita Anaheim West Dialysis-Davita Anaheim West Dialysis - Ismail ( Site 0562) Anaheim California 92801 —
DaVita Bakersfield Oak Street Dialysis-Clinical Research ( Site 0547) Bakersfield California 93304 —
Fresenius Kidney Care Bakersfield Northeast ( Site 0647) Bakersfield California 93306 —
Fresenius Kidney Care Meadows Field ( Site 0618) Bakersfield California 93308 —
California Institute Of Renal Research ( Site 0660) Chula Vista California 91910 —
Citrus Dialysis Center ( Site 0609) Covina California 91723 —
California Institute Of Renal Research ( Site 0679) El Centro California 92243 —
California Institute of Renal Research ( Site 0566) Escondido California 92025 —
Fresenius Kidney Care Newhope Fountain Valley ( Site 0617) Fountain Valley California 92708 —
DaVita Glendale Heights ( Site 0604) Glendale California 91201 —
DaVita West Glendale Dialysis ( Site 0579) Glendale California 91205 —
DaVita North Glendale ( Site 0552) Glendale California 91206 —
California Institute of Renal Research - La Mesa ( Site 0682) La Mesa California 91941 —
La Puente Dialysis Center ( Site 0610) La Puente California 91744 —
Academic Medical Research Institute ( Site 0533) Los Angeles California 90022 —
DaVita Kidney Center - East LA Plaza Dialysis ( Site 0548) Los Angeles California 90033 —
DaVita Crescent Heights Dialysis Center ( Site 0574) Los Angeles California 90048 —
North America Research Institute ( Site 0587) Lynwood California 90262 —
North America Research Institute ( Site 0612) Lynwood California 90262 —
Valley Renal Medical Group Research-Clinical Research ( Site 0651) Northridge California 91343 —
California Institute of Renal Research - Kearny Mesa ( Site 0678) San Diego California 92111 —
North America Research Institute ( Site 0611) San Dimas California 91773 —
DaVita Van Nuys Dialysis ( Site 0538) Van Nuys California 91405 —
Desert Cities Diaylsis-Clinical Research ( Site 0615) Victorville California 92392 —
DaVita Clinical Research - Hartford ( Site 0507) Hartford Connecticut 06112 —
DaVita Clinical Research - Middlebury ( Site 0511) Middlebury Connecticut 06762 —
Research Physicians Network Alliance ( Site 0563) Boca Raton Florida 33431 —
Horizon Research Group ( Site 0578) Coral Gables Florida 33134 —
Horizon Research Group ( Site 0581) Coral Gables Florida 33134 —
Elixia at Florida Kidney Physicians - Southeast ( Site 0602) Fort Lauderdale Florida 33308 —
South Florida Research Institute ( Site 0656) Fort Lauderdale Florida 33313 —
Elixia Clinical Research Collaborative (CRC) - Southeast Florida ( Site 0728) Hollywood Florida 33020 —
Pines Clinical Research ( Site 0605) Hollywood Florida 33024 —
Floridian Clinical Research, LLC ( Site 0684) Miami Lakes Florida 33016 —
Omega Research Orlando ( Site 0645) Orlando Florida 32808 —
Genesis Clinical Research, LLC ( Site 0585) Tampa Florida 33603 —
Genesis Clinical Research, LLC ( Site 0594) Tampa Florida 33603 —
Genesis Clinical Research, LLC ( Site 0680) Tampa Florida 33603 —
DaVita Clinical Research - Columbus ( Site 0532) Columbus Georgia 31904 —
Renal Physicians of Georgia ( Site 0577) Macon Georgia 31217 —
DaVita East Georgia Dialysis Unit ( Site 0536) Statesboro Georgia 30458 —
University of Chicago Medical Center-Medicine - Section of Nephrology ( Site 0595) Chicago Illinois 60637 —
Nephrology Specialists - Merrillville ( Site 0537) Merrillville Indiana 46410 —
Nephrology Specialists - Michigan City ( Site 0541) Michigan City Indiana 46360 —
Capital Nephrology ( Site 0596) Greenbelt Maryland 20770 —
Henry Ford Hospital-Nephrology and Hypertension ( Site 0694) Detroit Michigan 48202 —
St. Clair Nephrology Research - Roseville ( Site 0597) Roseville Michigan 48066 —
DaVita Clinical Research ( Site 0502) Minneapolis Minnesota 55404 —
Fresenius Kidney Care Brookhaven ( Site 0693) Brookhaven Mississippi 39601 —
Clinical Research Consultants, LLC ( Site 0542) Kansas City Missouri 64111 —
Somnos Clinical Research ( Site 0669) Lincoln Nebraska 68505 —
DaVita Five Star Dialysis Center ( Site 0509) Las Vegas Nevada 89128 —
Renal Medicine Associates ( Site 0690) Albuquerque New Mexico 87109 —
Capital District Renal Physicians ( Site 0633) Albany New York 12209 —
Ridgewood Dialysis Center ( Site 0725) Ridgewood New York 11385 —
Albert Einstein College of Medicine-Department of Medicine-Nephrology Einstein ( Site 0628) The Bronx New York 10461 —
DaVita Clinical Researh ( Site 0501) The Bronx New York 10461 —
Fresenius Kidney Care - Charlotte ( Site 0686) Charlotte North Carolina 28208 —
Durham Nephrology Associates ( Site 0655) Durham North Carolina 27704 —
East Carolina University-Department of Nephrology & Hypertension ( Site 0663) Greenville North Carolina 27834 —
Kidney and Hypertension Center ( Site 0571) Roseburg Oregon 97471 —
Northeast Clinical Research Center ( Site 0653) Bethlehem Pennsylvania 18017 —
Elixia at Clinical Renal Associates ( Site 0677) Upland Pennsylvania 19013 —
South Carolina Nephrology & Hypertension Center-Research ( Site 0672) Orangeburg South Carolina 29118 —
Knoxville Kidney Center ( Site 0689) Knoxville Tennessee 37923 —
Renal Disease Research Institute ( Site 0621) Dallas Texas 75235 —
DaVita Clinical Research - El Paso ( Site 0505) El Paso Texas 79925 —
DaVita Clinical Research - Houston ( Site 0508) Houston Texas 77004 —
Clinical Research Strategies ( Site 0625) Houston Texas 77090 —
Southwest Houston Research ( Site 0649) Houston Texas 77099 —
Texas Institute for Kidney and Endocrine Disorders ( Site 0626) Lufkin Texas 75904 —
Gamma Medical Research ( Site 0688) McAllen Texas 78503 —
DaVita Clinical Research - Norfolk ( Site 0513) Norfolk Virginia 23502 —
DaVita Clinical Research - Milwaukee ( Site 0512) Wauwatosa Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05027074, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 11, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05027074 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →